What is the future of Biogen?

Could you please elaborate on the potential future trajectory of Biogen, considering its current position in the biotechnology and pharmaceutical sector? Are there any promising drug candidates in their pipeline that could significantly impact the company's growth and market position? Additionally, how might regulatory changes or market trends affect their operations and prospects? Are there any notable challenges or risks that investors should be aware of when assessing the future of Biogen?